[{"address1": "2450 Holcombe Blvd", "address2": "MS: BCM251", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "713 400 6400", "website": "https://markertherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Juan F. Vera M.D.", "age": 44, "title": "Co-Founder, CEO, President, Treasurer, Secretary & Director", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 400000, "exercisedValue": 0, "unexercisedValue": 9390}, {"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Administration", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Maria-Bernadette  Madel Ph.D.", "age": 33, "title": "Director of Corporate Operations & External Communications", "yearBorn": 1991, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Allison", "title": "Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Newman Ph.D.", "age": 65, "title": "Head of Regulatory Affairs", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. F. Andrew Dorr M.D.", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr., Ph.D.", "title": "Senior Director of Molecular Biology & Virology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.19, "open": 1.2, "dayLow": 1.2, "dayHigh": 1.3, "regularMarketPreviousClose": 1.19, "regularMarketOpen": 1.2, "regularMarketDayLow": 1.2, "regularMarketDayHigh": 1.3, "payoutRatio": 0.0, "beta": 1.543, "forwardPE": -0.85616434, "volume": 87132, "regularMarketVolume": 87132, "averageVolume": 120488, "averageVolume10days": 41000, "averageDailyVolume10Day": 41000, "bid": 1.2, "ask": 1.56, "bidSize": 11, "askSize": 2, "marketCap": 13386250, "fiftyTwoWeekLow": 0.95, "fiftyTwoWeekHigh": 5.99, "priceToSalesTrailing12Months": 2.0309646, "fiftyDayAverage": 1.2802, "twoHundredDayAverage": 2.7955, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5806184, "profitMargins": -1.62816, "floatShares": 6524997, "sharesOutstanding": 10709000, "sharesShort": 197176, "sharesShortPriorMonth": 372541, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0184, "heldPercentInsiders": 0.093260005, "heldPercentInstitutions": 0.3955, "shortRatio": 3.21, "shortPercentOfFloat": 0.0256, "impliedSharesOutstanding": 10709000, "bookValue": 1.733, "priceToBook": 0.72129256, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -10731315, "trailingEps": -1.19, "forwardEps": -1.46, "lastSplitFactor": "1:10", "lastSplitDate": 1674777600, "enterpriseToRevenue": -0.881, "52WeekChange": -0.6958637, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 1.25, "targetHighPrice": 19.0, "targetLowPrice": 4.0, "targetMeanPrice": 10.33333, "targetMedianPrice": 8.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 19192440, "totalCashPerShare": 1.792, "totalDebt": 0, "quickRatio": 6.217, "currentRatio": 6.357, "totalRevenue": 6591080, "revenuePerShare": 0.734, "returnOnAssets": -0.35499, "returnOnEquity": -0.65814, "grossProfits": -6876765, "freeCashflow": -7127856, "operatingCashflow": -10910324, "revenueGrowth": 1.131, "grossMargins": -1.04334, "ebitdaMargins": 0.0, "operatingMargins": -1.7148399, "financialCurrency": "USD", "symbol": "MRKR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1746219230, "regularMarketTime": 1746216000, "exchange": "NCM", "messageBoardId": "finmb_1725474", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketPrice": 1.25, "regularMarketChangePercent": 5.0420117, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.19, "epsForward": -1.46, "epsCurrentYear": -1.29, "priceEpsCurrentYear": -0.9689923, "fiftyDayAverageChange": -0.030200005, "fiftyDayAverageChangePercent": -0.023590067, "twoHundredDayAverageChange": -1.5455, "twoHundredDayAverageChangePercent": -0.5528528, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "shortName": "Marker Therapeutics, Inc.", "longName": "Marker Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1026826200000, "postMarketChangePercent": -0.799999, "postMarketPrice": 1.24, "postMarketChange": -0.00999999, "regularMarketChange": 0.059999943, "regularMarketDayRange": "1.2 - 1.3", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 120488, "fiftyTwoWeekLowChange": 0.3, "fiftyTwoWeekLowChangePercent": 0.3157895, "fiftyTwoWeekRange": "0.95 - 5.99", "fiftyTwoWeekHighChange": -4.74, "fiftyTwoWeekHighChangePercent": -0.79131883, "fiftyTwoWeekChangePercent": -69.58637, "dividendDate": 1473984000, "earningsTimestamp": 1743425100, "earningsTimestampStart": 1747133940, "earningsTimestampEnd": 1747656000, "marketState": "CLOSED", "displayName": "Marker Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]